Psychemedics Stock Price on October 18, 2024

PMD Stock  USD 2.33  0.01  0.43%   
Below is the normalized historical share price chart for Psychemedics extending back to January 22, 1987. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Psychemedics stands at 2.33, as last reported on the 2nd of December, with the highest price reaching 2.34 and the lowest price hitting 2.32 during the day.
IPO Date
17th of February 1994
200 Day MA
2.474
50 Day MA
2.3258
Beta
0.674
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Psychemedics Stock, it is important to understand the factors that can impact its price. At this point, Psychemedics is somewhat reliable. Psychemedics maintains Sharpe Ratio (i.e., Efficiency) of 0.0347, which implies the firm had a 0.0347% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Psychemedics, which you can use to evaluate the volatility of the company. Please check Psychemedics' Risk Adjusted Performance of 0.0161, coefficient of variation of 4217.29, and Semi Deviation of 0.5281 to confirm if the risk estimate we provide is consistent with the expected return of 0.0223%.
  
At present, Psychemedics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 32.4 K, whereas Other Stockholder Equity is forecasted to decline to about 23.3 M. . As of December 2, 2024, Price To Sales Ratio is expected to decline to 0.73. The current year's Price Earnings Ratio is expected to grow to -3.89. Psychemedics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0347

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPMD

Estimated Market Risk

 0.64
  actual daily
5
95% of assets are more volatile

Expected Return

 0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average Psychemedics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Psychemedics by adding it to a well-diversified portfolio.
Price Book
2.5165
Enterprise Value Ebitda
12.9063
Price Sales
0.6635
Shares Float
4.3 M
Wall Street Target Price
32

Related Headline

Castle Biosciences Headline on 18th of October 2024

With the latest approval, ABBVs Vyalev becomes the first and only subcutaneous 24-hour infusion of levodopa-based therapy for treating advanced Parkinsons disease.

Psychemedics Valuation on October 18, 2024

It is possible to determine the worth of Psychemedics on a given historical date. On October 18, 2024 Psychemedics was worth 2.33 at the beginning of the trading date compared to the closed value of 2.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Psychemedics stock. Still, in general, we apply an absolute valuation method to find Psychemedics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Psychemedics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Psychemedics' related companies.
 Open High Low Close Volume
  2.32    2.32    2.31    2.31    9,420  
10/18/2024
  2.33    2.33    2.31    2.32    28,757  
  2.33    2.33    2.31    2.32    13,874  
Backtest Psychemedics  |  Psychemedics History  |  Psychemedics Valuation   PreviousNext  
Open Value
2.33
2.32
Closing Value
4.26
Upside

Psychemedics Trading Date Momentum on October 18, 2024

On October 21 2024 Psychemedics was traded for  2.32  at the closing time. Highest Psychemedics's price during the trading hours was 2.33  and the lowest price during the day was  2.31 . The net volume was 13.9 K. The overall trading history on the 21st of October did not cause price change. The trading delta at closing time to current price is 0.86% .

Psychemedics Fundamentals Correlations and Trends

By evaluating Psychemedics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Psychemedics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Psychemedics financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Psychemedics Stock history

Psychemedics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Psychemedics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Psychemedics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Psychemedics stock prices may prove useful in developing a viable investing in Psychemedics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding5.7 M5.4 M
Net Loss-975.6 K-926.8 K

Psychemedics Quarterly Net Working Capital

2.25 Million

Psychemedics Stock Technical Analysis

Psychemedics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Psychemedics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Psychemedics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Psychemedics Period Price Range

Low
December 2, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Psychemedics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Psychemedics December 2, 2024 Market Strength

Market strength indicators help investors to evaluate how Psychemedics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Psychemedics shares will generate the highest return on investment. By undertsting and applying Psychemedics stock market strength indicators, traders can identify Psychemedics entry and exit signals to maximize returns

Psychemedics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Psychemedics' price direction in advance. Along with the technical and fundamental analysis of Psychemedics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Psychemedics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Psychemedics Stock analysis

When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities